ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 762911 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 762911; 2) Community: the network communities that were significantly associated with the response to NSC 762911; 3) Molecule: the relationships between components within communities and NSC 762911; 4) MDR: the compounds that were significantly associated with the NSC 762911.

NSC Compound Enrichment Correlation
NSC 676028 Null 0.0342636096654276 -0.16599817
NSC 684481 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 2-(3-chloro- phenyl)-5,6-dihydro-4-phenyl- 0.0342636096654276 -0.34121421
NSC 687522 Null 0.0342636096654276 -0.19971346
NSC 687945 Benzoic acid, 2-hydroxy-4-[[(2,5-dihydroxyphenyl)-methyl]amino]-, methyl ester 0.0342636096654276 0.13518765
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 0.0342636096654276 0.3998122
NSC 709440 Null 0.0342636096654276 -0.019496988
NSC 714604 Purpureagitosid 0.0342636096654276 -0.03633243
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0342636096654276 0.19346253
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0342636096654276 0.02632541
NSC 733504 Everolimus 0.0342636096654276 -0.20823517
Total:75  Current:54    [First] [Prev] [Next] [Last]